A Comparison of Cognitive Function in Patients under Maintenance Treatment with Heroin, Methadone, or Buprenorphine and Healthy Controls: An Open Pilot Study

REFERENCES

• Bundesministerium fuer Gesundheit und soziale Sicherung. Drogen- und Suchtbericht [Drug and Addiction Report].Berlin 2008
   Google Scholar
• Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, Yurgelun-Todd DA. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol 2006; 14:157–164.
   PubMed Web of Science ®Google Scholar
• Pulvirenti L, Diana M. Drug dependence as a disorder of neural plasticity: Focus on dopamine and glutamate. Rev Neurosci 2001; 12:141–158.
   PubMed Web of Science ®Google Scholar
• Verdejo A, Toribio I, Orozco C, Puente KL, Perez-Garcia M. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend 2005; 78:283–288.
   PubMed Web of Science ®Google Scholar
• Curran HV, Kleckham J, Bearn J, Strang J, Wanigaratne S. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: A dose-response study. Psychopharmacology (Berl) 2001; 154:153–160.
   PubMed Web of Science ®Google Scholar
• Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive performance. Drug Alcohol Depend 2005; 78:225–230.
   PubMed Web of Science ®Google Scholar
• Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend 2006; 84:240–247.
   PubMed Web of Science ®Google Scholar
• Soyka M, Zingg C, Koller G, Hennig-Fast K. Cognitive function in short- and long-term substitution treatment: Are there differences? World J Biol Psychiatr 2011; 11:400–408.
   Google Scholar
• Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000; 95:687–695.
   PubMed Web of Science ®Google Scholar
• Lyvers M, Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav 2003; 28:605–611.
   PubMed Web of Science ®Google Scholar
• Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 2002; 67:41–51.
   PubMed Web of Science ®Google Scholar
• Davis PE, Liddiard H, McMillan TM. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend 2002; 67:105–108.
   PubMed Web of Science ®Google Scholar
• Mintzer MZ, Correia CJ, Strain EC. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug Alcohol Depend 2004; 74:205–209.
   PubMed Web of Science ®Google Scholar
• Kagerer S, Backmund M, Walcher S, Soyka M. Driving performance under maintenance treatment with buprenorphine (in German). Suchtmed 2002; 4:17–24.
   Google Scholar
• Lenne MG, Dietze P, Rumbold GR, Redman JR, Triggs TJ. The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving. Drug Alcohol Depend 2003; 72:271–278.
   PubMed Web of Science ®Google Scholar
• Schindler SD, Ortner R, Peternell A, Eder H, Opgenoorth E, Fischer G. Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res 2004; 10:80–87.
   PubMed Web of Science ®Google Scholar
• Soyka M, Hock B, Kagerer S, Lehnert R, Limmer C, Kuefner H. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: Results of a randomized clinical trial. J Clin Psychopharmacol 2005; 25:490–493.
   PubMed Web of Science ®Google Scholar
• Specka M, Finkbeiner T, Lodemann E, Leifert K, Kluwig J, Gastpar M. Cognitive-motor performance of methadone-maintained patients. Eur Addict Res 2000; 6:8–19.
   PubMed Web of Science ®Google Scholar
• Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P, Limmer C, Kuefner H, Hennig-Fast K. Cognitive functioning during methadone and buprenorphine treatment: Results of a randomized clinical trial. J Clin Psychopharmacol 2008; 28:699–703.
   PubMed Web of Science ®Google Scholar
• Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin-assisted treatment for opioid dependence: Randomised controlled trial. Br J Psychiatry 2007; 191:55–62.
   PubMed Web of Science ®Google Scholar
• Kisser R, Wenninger U. Computergestuetztes Testen im Rahmen der Fahreignungsuntersuchung (Act & React Test System ART-90). [Computerised Testing in Driver Selection]. Vienna, Austria: Kuratorium fuer Verkehrssicherheit, 1983.
   Google Scholar
• Lewrenz H. Krankheit und Kraftverkehr. Begutachtungs-Leitlinien des Gemeinsamen Beirats für Verkehrsmedizin beim Bundesministerium für Verkehr und beim Bundesministerium für Gesundheit. Bonn, Germany: Bundesministerium für Verkehr, 2000.
   Google Scholar
• Brunnauer A, Laux G, Geiger E, Moller HJ. The impact of antipsychotics on psychomotor performance with regards to car driving skills. J Clin Psychopharmacol 2004; 24:155–160.
   PubMed Web of Science ®Google Scholar
• Soyka M, Winter C, Kagerer S, Brunnauer M, Laux G, Moller HJ. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls. J Psychiatr Res 2005; 39:101–108.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009: CD002209.
   Google Scholar
• Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2008: CD002207.
   Google Scholar
• Ferri M, Davoli M, Perucci CA. Heroin maintenance treatment for chronic heroin-dependent individuals: A Cochrane systematic review of effectiveness. J Subst Abuse Treat 2006; 30:63–72.
   PubMed Web of Science ®Google Scholar
• Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009; 361:777–786.
   PubMed Web of Science ®Google Scholar
• Verthein U, Bonorden-Kleij K, Degkwitz P, Dilg C, Kohler WK, Passie T, Soyka M, Tanger S, Vogel M, Haasen C. Long-term effects of heroin-assisted treatment in Germany. Addiction 2008; 103:960–966, discussion 967–968.
   PubMed Web of Science ®Google Scholar
• Lee TM, Pau CW. Impulse control differences between abstinent heroin users and matched controls. Brain Inj 2002; 16:885–889.
   PubMed Web of Science ®Google Scholar
• Pau CW, Lee TM, Chan SF. The impact of heroin on frontal executive functions. Arch Clin Neuropsychol 2002; 17:663–670.
   PubMed Web of Science ®Google Scholar
• Dittert S, Naber D, Soyka M. [‘Methadone substitution therapy and driving’. Results of an experimental study]. Nervenarzt 1999; 70:457–462.
   PubMed Web of Science ®Google Scholar
• Zacny JP. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 1995; 3:432–466.
   Web of Science ®Google Scholar
• Messinis L, Lyros E, Andrian V, Katsakiori P, Panagis G, Georgiou V, Papathanasopoulos P. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy. Hum Psychopharmacol 2009; 24:524–531.
   PubMed Web of Science ®Google Scholar
• Mintzer MZ. Effects of opioid pharmacotherapy on psychomotor and cognitive performance: A review of human laboratory studies of methadone and buprenorphine. Heroin Addict Relat Clin Prob 2007; 9:5–24.
   Google Scholar
• Soyka M, Horak M, Dittert S, Kagerer S. Less driving impairment on buprenorphine than methadone in drug-dependent patients? J Neuropsychiatry Clin Neurosci 2001; 13:527–528.
   PubMedGoogle Scholar
• Loeber S, Kniest A, Diehl A, Mann K, Croissant B. Neuropsychological functioning of opiate-dependent patients: A nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment. Am J Drug Alcohol Abuse 2008; 34:584–593.
   PubMed Web of Science ®Google Scholar
• Soyka M, Kranzler HR, van den Brink W, Krystal J, Möller H-J, Kasper W. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. World J Biological Psychiatry 12:160–187.
   Google Scholar